Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/13/15 → 3/13/18 |
Funding
- Parexel (Prot #R668-AD-1334)
- Regeneron Pharmaceuticals, Inc. (Prot #R668-AD-1334)
Prot #R668-AD-1334: A Phase 3 Confirmatory Study Investigating the Efficacy and Safety of Dupilumab Monotherapy Administered to Adult Patients With Moderate-To-Severe Atopic Dermatitis
- Silverberg, Jonathan I (PD/PI)
Project: Research project